Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | CHKA | P35790 | 8/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29199774 | 0.98 | ALDH1A1 (0.43) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| Bromide SCHEMBL384556 | 0.98 | CHKA (0.47) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| SCHEMBL161677 | 0.92 | ALDH1A1 (0.39) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| SCHEMBL4531332 | 0.92 | ALDH1A1 (0.39) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| SCHEMBL1185630 | 0.90 | CHKA (0.41) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| SCHEMBL7995708 | 0.88 | CHKA (0.36) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| Acetonitrile SCHEMBL28221268 | 0.88 | CHKA (0.36) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| SCHEMBL3630115 | 0.88 | CHKA (0.36) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| SCHEMBL1185633 | 0.88 | CHKA (0.36) | ALDH1A1TSHRALOX15HSD17B10CHKA | |
| Trifluoromethanesulfonic Acid SCHEMBL4459808 | 0.81 | NSD2 (0.37) | ALDH1A1TSHRALOX15HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3927685-B1 | A PROCESS FOR THE SYNTHESIS ANTHRANILIC DIAMIDE COMPOUNDS AND INTERMEDIATES THEREOF | PI INDUSTRIES LTD (IN) | 2025-10-08 | — | — | EP | claimed |
| EP-3503917-B1 | MULTIVALENT VACCINE COMPOSITION | SERUM INSTITUTE OF INDIA PVT LTD (IN) | 2024-07-03 | — | — | EP | claimed |
| EP-3530285-B1 | METHOD FOR PRODUCING HIB CONJUGATE VACCINE USING PRP WITH
LOWERED MOLECULAR WEIGHT | KM BIOLOGICS CO LTD (JP) | 2023-08-09 | — | — | EP | claimed |
| WO-2023069278-A1 | CHEMICAL REAGENTS FOR THE ACTIVATION OF POLYSACCHARIDES IN THE PREPARATION OF CONJUGATE VACCINES | FINA BIOSOLUTIONS, LLC (US) | 2023-04-27 | — | — | WO | claimed |
| US-20230122876-A1 | Chemical Reagents for the Activation of Polysaccharides in the Preparation of Conjugate Vaccines | FINA BIOSOLUTIONS, LLC (US) | 2023-04-20 | — | — | US | claimed |
| US-20220257753-A1 | Vaccine Adjuvants for Antigen Delivery | SUBHADRA BOBBAN (US) | 2022-08-18 | — | — | US | claimed |
| EP-3923982-A1 | NEISSERIA MENINGITIDISCOMPOSITIONS AND METHODS THEREOF | Pfizer Inc. (US) | 2021-12-22 | — | — | EP | claimed |
| EP-2706991-B1 | MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF | CHILDRENS MEDICAL CENTER (US) | 2021-03-24 | — | — | EP | claimed |
| WO-2020165711-A1 | NEISSERIA MENINGITIDISCOMPOSITIONS AND METHODS THEREOF | PFIZER INC. (US) | 2020-08-20 | — | — | WO | claimed |
| US-9448241-B2 | Mass spectrometry method for a polypeptide including a cysteine residue | CANON KABUSHIKI KAISHA (JP) | 2016-09-20 | — | — | US | claimed |
| EP-1858551-A2 | COMBINATION VACCINES WITH WHOLE CELL PERTUSSIS ANTIGEN | Novartis Vaccines and Diagnostics S.r.l. (IT) | 2007-11-28 | — | — | EP | claimed |
| EP-1069909-B1 | CONJUGATE VACCINES FOR THE PREVENTION OF DENTAL CARIES | LEES ANDREW (US) | 2007-06-13 | — | — | EP | claimed |
| WO-2006097851-A2 | COMBINATION VACCINES WITH WHOLE CELL PERTUSSIS ANTIGEN | NOVARTIS VACCINES AND DIAGNOSTICS SRL (IT) | 2006-09-21 | — | — | WO | claimed |
| EP-1272530-B1 | CLATHRATE COMPLEXES FORMED BY HYALURONIC ACID DERIVATIVES AND USE THEREOF AS PHARMACEUTICALS | FIDIA FARMACEUTICI (IT) | 2006-09-20 | — | — | EP | claimed |
| US-20040185525-A1 | Process for producing peptide | SHIMADZU CORPORATION (JP) | 2004-09-23 | — | — | US | claimed |
| EP-1391518-A1 | PROCESS FOR PRODUCING PEPTIDE | Takeda Chemical Industries, Ltd. (JP) | 2004-02-25 | — | — | EP | claimed |
| EP-0814833-B1 | PRODUCING IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED VIA ORGANIC CYANYLATING REAGENTS | JACKSON H M FOUND MILITARY MED (US) | 2003-05-28 | — | — | EP | claimed |
| EP-0506431-B1 | Modified enzyme | WAKO PURE CHEM IND LTD (JP) | 1998-01-28 | — | — | EP | claimed |
| EP-0222380-B1 | METHOD FOR STABILIZING CREATINE KINASE | Roche Diagnostics GmbH (DE) | 1993-03-17 | — | — | EP | claimed |
| EP-0506431-A1 | Modified enzyme | WAKO PURE CHEMICAL INDUSTRIES LTD (JP) | 1992-09-30 | — | — | EP | claimed |